Intellia Therapeutics
NTLA
#5291
Rank
S$1.92 B
Marketcap
S$16.58
Share price
-0.68%
Change (1 day)
27.01%
Change (1 year)

EPS for Intellia Therapeutics (NTLA)

EPS in 2025 (TTM): S-$5.64

According to Intellia Therapeutics's latest financial reports the company's current EPS (TTM) is S-$5.42. In 2024 the company made an earnings per share (EPS) of S-$6.66 an increase over its 2023 EPS that were of S-$6.87.

EPS history for Intellia Therapeutics from 2016 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$5.64-15.43%
2024S-$6.66-2.96%
2023S-$6.87-12.46%
2022S-$7.8564.36%
2021S-$4.7756.67%
2020S-$3.05
2018S-$2.536.99%
2017S-$2.3671.4%
2016S-$1.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
S-$2.20-59.48%๐Ÿ‡บ๐Ÿ‡ธ USA